BioSpace News Archive

Symbility Solutions Inc. confirmed that it will release its second quarter financial results for the three months ended June 30, 2018

Bristol-Myers Squibb Company (NYSE:BMY) today announced that Opdivo (nivolumab) received approval from the U.S. Food and Drug Administration (FDA) as the first and only Immuno-Oncology treatment option for patients with metastatic small cell lung cancer (SCLC) whose cancer has progressed after platinum-based chemotherapy and at least one other line of therapy.

Quantzig, a global analytics solutions provider, has announced the completion of their latest article on the benefits of real world evidence for pharma companies.

Bonita Springs-based franchisor draws recognition for rapid expansion

Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations,

Stress incontinence. Vaginal dryness. OAB. Those are just a select few of any number of challenging, oftentimes painful vaginal health conditions that impact millions of women every year. What’s even more challenging for the mothers, daughters, sisters, women in our lives?

According to the data published by Energias Market Research, the global medical cannabis market is projected to grow from USD 8.28 Billion in 2017 to USD 28.07 Billion in 2024 and at a CAGR of 19.1% from 2018 to 2024.

Medical Marijuana, Inc. announced today that its subsidiary Kannaway® will host a European tour during the month of August.

Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD).

The Medical Science Liaison Society (MSL Society), the only 501(c)(3) non-profit organization exclusively dedicated to advancing the global medical science liaison (MSL) profession, has announced the finalists for the first-ever MSL of the Year Awards.